| |
| Issue |
Title |
| |
| No 2 (2025) |
Pharmacokinetics of metoprolol tartrate in patients with and without controlled arterial hypertension |
Abstract
PDF (Rus)
|
|
S. V. Seleznev, A. V. Shchulkin, P. Yu. Mylnikov, N. V. Enenkov |
| |
| No 2 (2025) |
Identification of subjects with low baseline variability in pharmacokinetic parameters in clinical trials using bioimpedance analysis |
Abstract
PDF (Rus)
|
|
A. B. Verveda, V. B. Vasilyuk, G. I. Syraeva, M. V. Faraponova |
| |
| No 1 (2025) |
Valsartan pharmacokinetics in patients with controlled and uncontrolled arterial hypertension |
Abstract
PDF (Rus)
|
|
S. V. Seleznev, P. Yu. Mylnikov, A. V. Shchulkin |
| |
| No 4 (2024) |
Prognostic impact of clinical and genetic factors on delayed elimination of methotrexate in children with acute lymphoblastic leukemia |
Abstract
PDF (Rus)
|
|
O. D. Gurieva, M. I. Savelyeva, T. T. Valiev, S. R. Varfolomeeva, M. V. Ilyin |
| |
| No 1 (2017) |
Clinical pharmacokinetics of а new original dipeptide anxiolytic GB-115 |
Abstract
PDF (Rus)
|
|
V. P. Zherdev, G. B. Kolyvanov, A. A. Litvin, V. V. Smirnov, L. G. Kolik, S. Yu. Raskin, N. Yu. Ivashkina, T. A. Gudasheva, S. B. Seredenin |
| |
| No 1 (2017) |
Pharmacokinetic study of prolonged release capsules of mebeverine |
Abstract
PDF (Rus)
|
|
A. L. Khokhlov, Yu. A. Dzhurko, L. N. Shitov, I. I. Yaichkov, A. M. Shitova, L. A. Khozova, A. E. Miroshnikov |
| |
| 1 - 6 of 6 Items |
|
